Vidiia
Vidiia is a UK-based company specializing in rapid, cost-effective, on-site diagnostic solutions leveraging AI-powered technologies. Originating from collaborations among leading UK universities, Vidiia transforms academic research into impactful, portable diagnostics for healthcare, veterinary, agriculture, food safety, and environmental applications. Their key products include the VH-Platform, a suite of tools for fast, decentralized testing, and the Assay Accelerator, which supports assay development from concept to commercial deployment. Vidiia's COVID-19 test achieved UK government approval with high sensitivity and specificity, demonstrating their capability to deliver reliable diagnostics. The company aims to accelerate 100 diagnostic assays by 2029, focusing on democratizing access to affordable, AI-driven testing technologies globally, thus bridging the gap between research and real-world application.
Vidiia
Vidiia is a UK-based company specializing in rapid, cost-effective, on-site diagnostic solutions leveraging AI-powered technologies. Originating from collaborations among leading UK universities, Vidiia transforms academic research into impactful, portable diagnostics for healthcare, veterinary, agriculture, food safety, and environmental applications. Their key products include the VH-Platform, a suite of tools for fast, decentralized testing, and the Assay Accelerator, which supports assay development from concept to commercial deployment. Vidiia's COVID-19 test achieved UK government approval with high sensitivity and specificity, demonstrating their capability to deliver reliable diagnostics. The company aims to accelerate 100 diagnostic assays by 2029, focusing on democratizing access to affordable, AI-driven testing technologies globally, thus bridging the gap between research and real-world application.